PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Feb-2024 Global Arteriovenous Fistula Treatment Industry is expected to experience sustained growth of a 5.9% CAGR, potentially reaching US$ 1,356.5 Million by 2033 | FMI MARKITWIRED
02-Feb-2024 Global Cardiac Rhythm Remote Monitoring Devices Industry is anticipated to exceed US$ 7,985.6 Million by 2033, propelled by advancements in integration with electronic health records | FMI MARKITWIRED
02-Feb-2024 Global Cryoballoon Ablation System Industry reaching US$ 1.8 Billion by 2033, with a growth rate of 4.9% | FMI MARKITWIRED
02-Feb-2024 Global Blood Fluid Warming System Industry Set to Surge, Projected to Reach US$ 2,264.6 Million by 2033 grow at a 7.6% CAGR | FMI MARKITWIRED
02-Feb-2024 Global Nasal Packing Devices Industry is set to witness a substantial uptick to US$ 311.9 Million by 2033, driven by progress in treating epistaxis, states FMI MARKITWIRED
02-Feb-2024 Robotics and Automation in Pharmaceutical Manufacturing Globose Technology Solution
02-Feb-2024 Domrex Pharma Inc. Expands Presence in the United States Businesswire
02-Feb-2024 Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Feb-2024 Baron & Budd Named to U.S. News & World Report 2024 Best Companies to Work For: Law Firms Businesswire
02-Feb-2024 Ted Love, MD, Joins Gilead Sciences’ Board of Directors Businesswire
02-Feb-2024 Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences Businesswire
02-Feb-2024 Takeda gibt Nachfolger für die Position des Chief Financial Officer bekannt Businesswire
02-Feb-2024 Takeda annonce la succession de son directeur financier Businesswire
02-Feb-2024 Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February Businesswire
02-Feb-2024 Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024 Businesswire
01-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Evolution AB (EVVTY) on Behalf of Investors Businesswire
01-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SiTime Corporation (SITM) on Behalf of Investors Businesswire
01-Feb-2024 Takeda anuncia sucessão do diretor financeiro Businesswire
01-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Silicon Laboratories Inc. (SLAB) on Behalf of Investors Businesswire
01-Feb-2024 Bausch Health Announces Board Refreshment AccessWire